Clinical Trials
5 trialsNCT00000660 2021-11-03
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00000807 2021-10-28
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01352117 2019-11-14
REACT-KS
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Phase 3 Completed
NCT00003657 2017-01-20
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00002936 2013-02-04
Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
Roswell Park Cancer Institute
Phase 1 Completed